Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand Medical Dialogues Bureau24 March 2020 12:35 PM ISTThe drugmaker said in a statement there had been an exponential increase in so-called compassionate-use requests for the drug
Gilead's drug leads global race to find virus treatment Medical Dialogues Bureau26 Feb 2020 2:24 PM ISTBeijing | Tokyo: China will release results at the end of April from clinical trials of a Gilead Sciences drug that is emerging as a frontrunner in...
Coronavirus: Gilead drug remdesivir raises hope for China trials Medical Dialogues Bureau14 Feb 2020 12:42 PM ISTA state-run Chinese research institute applied last week fora patent to use Gilead's experimental drug- remdesivir against the new coronavirus.
Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China Medical Dialogues Bureau1 Feb 2020 12:38 PM IST Gilead Sciences Inc said it was also expediting laboratory testing of the antiviral drug, remdesivir, against samples of the new coronavirus, which...
Merck loses bid to revive over Rs 18 crore patent verdict against Gilead Farhat Nasim31 Oct 2019 3:27 PM ISTIn 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it...
Novartis, Gilead costly cancer therapies Yescarta, Kymriah losing patients to experimental treatments Medical Dialogues Bureau3 Aug 2019 9:15 AM ISTBoth Gilead's Yescarta and Novartis's Kymriah - which are part of a class of therapies known in the medical field as "CAR-T" - were approved in 2017....
Gilead licenses respiratory, herpes antiviral research programs from Novartis Medical Dialogues Bureau23 July 2019 9:15 AM ISTUnder the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets....
Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report Medical Dialogues Bureau15 July 2019 9:30 AM ISTThe deal is the largest Gilead has executed since new Chief Executive Officer Dan O'Day took the reins in March as he attempts to bolster the San...
GSK gets USFDA nod for HIV-1 drug branded as Dovato Farhat Nasim9 April 2019 9:20 AM ISTGSK already has two-drug regimen Juluca on the market, but only for the smaller market of HIV patients that have received prior treatment. Dovato is...
US court upholds dismissal of 200 million dollars Merck verdict against Gilead Ruby Khatun Khatun27 April 2018 9:30 AM ISTA U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict Ruby Khatun Khatun19 Feb 2018 9:45 AM ISTA federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs...
